You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Drug Price Trends for DAYTIME SEVERE COLD-FLU CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DAYTIME SEVERE COLD-FLU CAPLET

Average Pharmacy Cost for DAYTIME SEVERE COLD-FLU CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DAYTIME SEVERE COLD-FLU CAPLET 70000-0636-01 0.13926 EACH 2025-04-23
DAYTIME SEVERE COLD-FLU CAPLET 70000-0636-01 0.13605 EACH 2025-03-19
DAYTIME SEVERE COLD-FLU CAPLET 70000-0636-01 0.13136 EACH 2025-02-19
DAYTIME SEVERE COLD-FLU CAPLET 70000-0636-01 0.13108 EACH 2025-01-22
DAYTIME SEVERE COLD-FLU CAPLET 70000-0636-01 0.12942 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for DAYTIME SEVERE COLD-FLU CAPLET

Market Overview of Cold and Flu Drugs

The cold and flu drugs market is experiencing significant growth, driven by several key factors. The global market size for cold and flu drugs was valued at USD 16.85 billion in 2024 and is projected to reach USD 29.39 billion by 2031, growing at a CAGR of 7.20% from 2024 to 2031[3].

Increasing Demand and Consumer Preferences

The COVID-19 pandemic has heightened awareness and concern about respiratory illnesses, leading to an increased demand for cold and flu treatments. Consumers are shifting towards natural and organic remedies, and there is a growing preference for drugs with immunity-boosting properties[1][4].

Market Trends and Insights

Revenue and Sales Growth

In the 2023-2024 cold and flu season, the market segment excluding cough suppressants saw a 39% surge in revenue and a 32% increase in unit sales on Amazon. This growth is attributed to increased consumer demand rather than price hikes[1].

Leading Products and Brands

Top-selling products in the cold and flu relief market include NyQuil Severe Cold and Flu Relief Liquid, Boiron’s Oscillococcinum tablets, and Zicam’s cold-shortening medicine. These products have seen significant revenue increases, with NyQuil’s revenue up by 718% over the past 90 days compared to the previous year[1].

Product Details: DAYTIME SEVERE COLD-FLU CAPLET

Active Ingredients and Uses

DAYTIME SEVERE COLD-FLU CAPLET contains acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride. These ingredients provide relief from symptoms such as minor aches and pains, headache, sore throat, nasal congestion, and cough. The product helps loosen phlegm and temporarily reduces fever[2][5].

Safety and Usage

The product carries a liver warning, as it contains acetaminophen, which can cause severe liver damage if taken in excess. It is advised not to take more than the directed dose, and users are cautioned against taking it with other drugs containing acetaminophen or consuming three or more alcoholic drinks daily while using the product[2][5].

Price Projections and Market Dynamics

Market Growth Drivers

The cold and flu drugs market is driven by seasonal variations, outbreaks, and increased financial investments in research and development. The growing aging population, particularly in North America, and rising healthcare expenditure also contribute to the market's growth[3][4].

Competitive Landscape

The market is highly competitive, with numerous brands and products available. The presence of private labels and the increasing availability of products through telemedicine and internet pharmacies are expected to further boost the market[1][4].

Price Trends

Given the increasing demand and stable median prices observed in recent trends, it is likely that the prices of DAYTIME SEVERE COLD-FLU CAPLET will remain relatively stable or see a moderate increase. The median price in the cold and flu relief market on Amazon remained steady despite a 39% revenue surge, indicating that price hikes are not the primary driver of market growth[1].

Regional Market Analysis

North America

North America dominates the cold and flu drugs market due to the high incidence of respiratory illnesses and an advanced healthcare infrastructure. The United States alone experiences millions of flu cases annually, contributing to a robust demand for cold and flu treatments[3].

Asia Pacific

The Asia Pacific region is experiencing rapid growth, driven by a large and expanding population, rising urbanization, and increased pollution levels. This region's growing middle class and rising disposable incomes enable more people to invest in healthcare products, including over-the-counter medications[3].

Opportunities for Brands

Capitalizing on Trends

Brands can capitalize on the growing demand by layering insights from the latest Amazon trends, market share data, sales trends, and consumer preferences. This involves identifying and capitalizing on potential growth areas, such as the increasing preference for natural and organic remedies[1].

Innovations and R&D

Significant investments in research and development, such as the creation of novel antiviral medicines and innovative drug delivery systems, are expected to drive market growth. Manufacturers' increased investments in drug development will continue to propel sales during the forecast period[3][4].

Key Takeaways

  • The cold and flu drugs market is projected to grow significantly, driven by increased demand, seasonal variations, and advancements in R&D.
  • DAYTIME SEVERE COLD-FLU CAPLET, with its active ingredients, is well-positioned to benefit from these market trends.
  • Prices are likely to remain stable or see a moderate increase due to stable median prices and increasing demand.
  • Brands should focus on consumer preferences for natural and organic remedies and leverage insights from market trends to capitalize on growth opportunities.

FAQs

Q: What are the key drivers of the cold and flu drugs market?

The market is driven by seasonal variations, outbreaks, increased financial investments in R&D, and a growing aging population.

Q: How is the demand for cold and flu treatments expected to change in the coming years?

Demand is expected to stay high due to heightened awareness of flu prevention and health management, particularly during the pandemic.

Q: What are the active ingredients in DAYTIME SEVERE COLD-FLU CAPLET?

The product contains acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride.

Q: What safety precautions should users take when using DAYTIME SEVERE COLD-FLU CAPLET?

Users should not take more than the directed dose, avoid taking it with other drugs containing acetaminophen, and not consume three or more alcoholic drinks daily while using the product.

Q: How is the competitive landscape in the cold and flu drugs market?

The market is highly competitive with numerous brands and products available, including private labels, and is further boosted by the increasing availability of products through telemedicine and internet pharmacies.

Sources

  1. Amazon Market Watch: Cold & Flu Season Trends & Top Sellers - Jungle Scout
  2. TYLENOL® Cold & Flu Severe Caplets - Tylenol
  3. Cold And Flu Drugs Market Size, Share, Trends & Forecast - Verified Market Research
  4. Cold and Flu Drugs Market: Industry Analysis 2030 - Stellar Market Research
  5. Label: DAYTIME SEVERE COLD AND FLU- acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride capsule, liquid filled - DailyMed
Last updated: 2025-01-02

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.